2 reduced payments for all office imaging to the lower of the 2 schedules. This resulted in dramatic cuts in Medicare revenues to owners of advanced imaging equipment in private offices. It was estimated that the average reduction in technical component payments in offices was 35% for MRI, 25% for MR angiography, 9% for CT, 37% for CT angiography, and 16% for nuclear medicine [5] . By making these cuts, federal policymakers hoped to save money by reducing the fees and also by reducing the incentive for physicians to place advanced imaging equipment in their offices.
In 2008, the Government Accountability Office (GAO) issued its first report on the effect of the DRA on imaging costs [3, 6] . It indicated that Medicare Part B spending for imaging had grown from $6. Not surprisingly, these steep cuts sparked dismay and anger within the radiology community. This was compounded by the fact that a number of commercial payers adopted similar cuts [7] . The ACR and the National Electrical Manufacturers Association (NEMA) and several other organizations jointly formed the Access to Medical Imaging Coalition (AMIC), which attempted to overturn the DRA [8] , but to no avail. A number of web sites representing various organizations weighed in with commentary on the DRA, all of it expressing concerns about the effects of the Act [8] [9] [10] [11] [12] [13] [14] [15] . The concerns were that private office imaging facilities would be forced to close, that advanced imaging exams might therefore have to be shifted to less convenient hospital outpatient departments, and that access for patients might be jeopardized. Three years of nationwide Medicare data (2007) (2008) (2009) ) is now available since the DRA took effect, and we wished to use these data to see if the Act has produced those effects.
Methods and Materials
We The volumes reported here are complete population counts. Therefore, they do not require inferential statistics, which test the relationship of a sample to a population. Table 1 As noted in Table 1 (the first year the DRA was in effect), then volumes remained stable during the last 2 years of the study. It seems apparent from this and other studies [18] that a dramatic slowdown in growth of imaging began around the middle of the last decade, after years of rapid increases. . The slowdown was not due to the DRA, or at least not solely to the DRA. The proof of this is that the slowdown was felt equally in HOPDs, which should not have been affected by the DRA. Moreover, the slowdown first became noticeable in 2005, even before the DRA was passed. There are several possible explanations for this 8 trend [18] . First, there has been extensive discussion in recent years within the health care industry about the need to reduce costs, and physicians may be getting more cost-conscious. Second, there has been concern expressed about radiation exposure [19] [20] [21] [22] and ordering physicians may be responding to that.
Results
Third, both the American College of Radiology and the American College of Cardiology have developed appropriateness criteria for imaging [23] [24] [25] , and physicians may be paying more attention to these criteria. Fourth, the recession could be implicated, although the slowdown predates the onset of the recession by several years. Fifth, the commercial payers have in some cases begun taking steps to limit the specialties that are eligible for reimbursement for advanced imaging [26] , and this may have helped cut down on self-referral. Finally, radiology benefits management companies (RBMs) have instituted preauthorization programs within the commercially insured population in recent years. Preauthorization is now in widespread use and makes it somewhat more difficult and inconvenient for physicians to order advanced imaging studies. Although traditional fee-for-service Medicare has not yet employed preauthorization, it seems likely that the RBMs have influenced ordering physicians and induced them to think more carefully about what imaging tests they order (or whether they should order them at all).
We believe that of the six factors discussed above, the RBMs are probably the principal one behind the growth slowdown reported herein.
A possible limitation of this study is that we evaluated overall utilization of advanced imaging, but did not compare the trends among radiologists and nonradiologist physicians. To make such a comparison would have entailed using a different methodology, which was not compatible with the aims of this study. Such a comparison has been made in the past [4] with data from 2007, the first year the DRA was in effect.
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There are several perspectives from which to view these data. From the perspective of health policy planners and federal government officials, the DRA appears to have achieved some of its goals.
Payments for imaging were sharply reduced and it does not yet seem that access for seniors to CT and MRI has been compromised. Our perspective as radiologists is less sanguine, however. Nuclear As radiologists, we can take some satisfaction in the remarkable flattening of the rapid growth in outpatient advanced imaging that our data demonstrate. This was a concern for health policy planners and now that growth has abated, there should be less downward pressure on imaging fees. Radiologists can also claim some credit for helping maintain access. In many instances, it is likely they were able to tighten their belts, institute new information technologies and work flows, and in general work harder and more efficiently. This may have allowed them to keep their office facilities in operation despite lower Medicare revenues.
In conclusion, we have examined recent trends in Medicare utilization of outpatient advanced imaging. 
